These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38387898)

  • 1. [Effect of
    Wang J; Wang ZJ; Li ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):45-51. PubMed ID: 38387898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Quercetin on Wnt/β-Catenin Signal Pathway of K562 and K562R Cells].
    Li W; Zhao Y; Qiu L; Ma J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1409-1415. PubMed ID: 31607291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
    Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS
    Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].
    Jiang HN; Liu ZG; Hu R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
    Xiao Y; Deng T; Ming X; Xu J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
    Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
    Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Stably Down-regulating FMI Expression of K562 Cells on Sensitivity of K562 cells to Imatinib Mesylate].
    Han YH; Zhang HX; Hong F; Yu D; Hu CY; Sun Q; Zeng LY; Li ZY; Yan ZL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):708-716. PubMed ID: 31204920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LY294002 Enhaces Chemosensitivity of K562 Cells to Daunorubicin].
    Geng YH; Wu WJ; Li J; Zhou LL; Yang YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):110-118. PubMed ID: 32027262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.
    Corrêa S; Binato R; Du Rocher B; Castelo-Branco MT; Pizzatti L; Abdelhay E
    BMC Cancer; 2012 Jul; 12():303. PubMed ID: 22823957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the Effect and Mechanism of Tetrandrine on Bone Marrow Mesenchymal Stem Cell-Mediated Drug Resistance in Leukemia].
    Zhou XY; Jin N; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):33-38. PubMed ID: 38387896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma.
    Chen G; Chen W; Ye M; Tan W; Jia B
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30389710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
    Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
    Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
    Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis.
    Xu XH; Gan YC; Xu GB; Chen T; Zhou H; Tang JF; Gu Y; Xu F; Xie YY; Zhao XY; Xu RZ
    J Zhejiang Univ Sci B; 2012 Nov; 13(11):867-74. PubMed ID: 23125079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571.
    Tabrizi R; Mahon FX; Cony Makhoul P; Lagarde V; Lacombe F; Berthaud P; Melo JV; Reiffers J; Belloc F
    Leukemia; 2002 Jun; 16(6):1154-9. PubMed ID: 12040447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
    Zhu XS; Lin ZY; Du J; Cao GX; Liu G
    Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt/β‑catenin pathway.
    Ma W; Liu F; Yuan L; Zhao C; Chen C
    Oncol Rep; 2020 Jan; 43(1):260-269. PubMed ID: 31746437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β.
    Fan RF; Lu Y; Fang ZG; Guo XY; Chen YX; Xu YC; Lei YM; Liu KF; Lin DJ; Liu LL; Liu XF
    Mol Med Rep; 2017 Oct; 16(4):4603-4612. PubMed ID: 28849186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
    Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
    Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.